Clinical global impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders
PINNA, FEDERICAFirst
;DERIU, LUCA;DIANA, ENRICA;PERRA, VALERIA;TUSCONI, MASSIMO;CARPINIELLO, BERNARDO;ARU, DAVIDEMember of the Collaboration Group
;BANDECCHI, CHIARAMember of the Collaboration Group
;CORDA, ELENAMember of the Collaboration Group
;FATTERI, FRANCESCAMember of the Collaboration Group
;GHIANI, ALICEMember of the Collaboration Group
;LAI, ALICEMember of the Collaboration Group
;LEPORI, TIZIANAMember of the Collaboration Group
;MACCIONI, RAFAELLAMember of the Collaboration Group
;MILIA, PAOLAMember of the Collaboration Group
;PINTORE, SONIA MARIAMember of the Collaboration Group
;PUDDU, LAURAMember of the Collaboration Group
;SARRITZU, ELISABETTAMember of the Collaboration Group
;
2015-01-01
Abstract
Aims: This study aimed to compare the performance of Positive and Negative Syndrome Scale (PANSS) symptom severity criteria established by the Remission in Schizophrenia Working Group (RSWG) with criteria based on Clinical Global Impression (CGI) severity score. The 6-month duration criterion was not taken into consideration. Methods: A convenience sample of 112 chronic psychotic outpatients was examined. Symptomatic remission was evaluated according to RSWG severity criterion and to a severity criterion indicated by the overall score obtained at CGI-Schizophrenia (CGI-SCH) rating scale (≤3) (CGI-S). Results: Clinical remission rates of 50% and 49.1%, respectively, were given by RSWG and CGI-S, with a significant level of agreement between the two criteria in identifying remitted and non-remitted cases. Mean scores at CGI-SCH and PANSS scales were significantly higher among remitters, independent of the remission criteria adopted. Measures of cognitive functioning were largely independent of clinical remission evaluated according to both RSWG and CGI-S. When applying RSWG and CGI-S criteria, the rates of overall good functioning yielded by Personal and Social Performance scale (PSP) were 32.1% and 32.7%, respectively, while the mean scores at PSP scale differed significantly between remitted and non-remitted patients, independent of criteria adopted. The proportion of patients judged to be in a state of well-being on Social Well-Being Under Neuroleptics-Short Version scale (SWN-K) were, respectively, 66.1% and 74.5% among remitters according to RSWG and CGI-S; the mean scores at the SWN scale were significantly higher only among remitters according to CGI-S criteria. Conclusions: CGI severity criteria may represent a valid and user-friendly alternative for use in identifying patients in remission, particularly in routine clinical practiceFile | Size | Format | |
---|---|---|---|
CGI remission AGP.pdf open access
Type: versione editoriale
Size 372.93 kB
Format Adobe PDF
|
372.93 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.